204322-78-1 Usage
Molecular Structure
1H-1-Benzazepine-1-acetic acid,3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3,4,5-tetrahydro-2-oxo-(9CI) has a complex molecular structure that includes a benzazepine ring, an acetic acid group, a tetrahydro-2-oxo moiety, an amino group, and a fluoren-9-ylmethoxy carbonyl group.
Benzazepine Ring
The compound contains a benzazepine ring, which is a tricyclic structure consisting of a benzene ring fused to a seven-membered azepine ring.
Acetic Acid Group
The compound has an acetic acid group (-COOH) attached to the molecular structure, which is a functional group commonly found in carboxylic acids.
Tetrahydro-2-oxo Moiety
The molecule features a tetrahydro-2-oxo moiety, which is a four-membered ring with two oxygen atoms and two hydrogen atoms.
Amino Group
The compound contains an amino group (-NH2), which is a functional group consisting of a nitrogen atom bonded to two hydrogen atoms.
Fluoren-9-ylmethoxy Carbonyl Group
The molecule has a fluoren-9-ylmethoxy carbonyl group (-C(O)NH(CH3)C12H9), which is a derivative of the fluorene structure with a methoxy group attached to the 9-position and an amino acid group in the form of a carbonyl.
1H-1-Benzazepine Derivative
This chemical compound is categorized as a 1H-1-benzazepine derivative, which is a group of compounds with potential applications in various fields.
Applications
The compound can be utilized in various fields such as pharmaceuticals, organic synthesis, and research, although its precise properties and uses would need to be further studied and determined by experts in the field.
Check Digit Verification of cas no
The CAS Registry Mumber 204322-78-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,3,2 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 204322-78:
(8*2)+(7*0)+(6*4)+(5*3)+(4*2)+(3*2)+(2*7)+(1*8)=91
91 % 10 = 1
So 204322-78-1 is a valid CAS Registry Number.
